The panel stressed the dynamic nature of decision-making in the pharmaceutical industry, the importance of continuous monitoring, and the need for effective knowledge management to support informed choices at every stage of drug development. Challenges include decision-making in different-sized organizations, resource availability, decision-making culture, and stakeholder preferences.